Some scientists say masks could reduce the risk of coronavirus infection. Credit: Pablo Monsalve/VIEWpress/Getty
Since early reports revealed that a new coronavirus was
spreading rapidly between people, researchers have been trying to pin
down whether it can travel through the air. Health officials say the
virus is transported only through droplets that are coughed or sneezed
out — either directly, or on objects. But some scientists say there is
preliminary evidence that airborne transmission — in which the disease
spreads in the much smaller particles from exhaled air, known as
aerosols — is occurring, and that precautions, such as increasing
ventilation indoors, should be recommended to reduce the risk of
infection.
In a scientific brief posted to its website on 27 March, the
World Health Organization said that there is not sufficient evidence to
suggest that SARS-CoV-2 is airborne, except in a handful of medical
contexts, such as when intubating an infected patient.
But experts
that work on airborne respiratory illnesses and aerosols say that
gathering unequivocal evidence for airborne transmission could take
years and cost lives. We shouldn’t “let perfect be the enemy of
convincing”, says Michael Osterholm, an infectious-disease
epidemiologist at the University of Minnesota in Minneapolis.
“In
the mind of scientists working on this, there’s absolutely no doubt that
the virus spreads in the air,” says aerosol scientist Lidia Morawska at
the Queensland University of Technology in Brisbane, Australia. “This
is a no-brainer.”
Confusing definitions
When public health
officials say there isn't sufficient evidence to say that SARS-CoV-2 is
airborne, they specifically mean transported in virus-laden aerosols
smaller than 5 micrometres in diameter. Compared with droplets, which
are heftier and thought to travel only short distances after someone
coughs or sneezes before falling to the floor or onto other surfaces,
aerosols can linger in the air for longer and travel further.
Most
transmission occurs at close range, says Ben Cowling, an epidemiologist
at the University of Hong Kong. But the distinction between droplets
and aerosols is unhelpful because “the particles that come out with
virus can be a wide range of sizes. Very, very large ones right down to
aerosols”, he says.
And if SARS-CoV-2 is transmitting in
aerosols, it is possible that virus particles can build up over time in
enclosed spaces or be transmitted over greater distances.
Aerosols are also more likely to be produced by talking and
breathing, which might even constitute a bigger risk than sneezing and
coughing, says virologist Julian Tang at the University of Leicester,
UK. “When someone’s coughing, they turn away, and when they’re sneezing,
they turn away,” he says. That’s not the case when we talk and breathe.
A study of people with influenza found that 39% of people exhaled infectious aerosols5.
As long as we are sharing an airspace with someone else, breathing in
the air that they exhale, airborne transmission is possible, says Tang.
The evidence so far
Evidence
from preliminary studies and field reports that SARS-CoV-2 is spreading
in aerosols is mixed. At the height of the coronavirus outbreak in
Wuhan, China, virologist Ke Lan at Wuhan University collected samples of
aerosols in and around hospitals treating people with COVID-19, as well
as at the busy entrances of two department stores.
In an unreviewed preprint1, Lan and his colleagues report finding viral RNA from SARS-CoV-2 in a number of locations, including the department stores.
The study doesn’t ascertain whether the aerosols collected were able to infect cells. But, in an e-mail to Nature,
Lan says the work demonstrates that “during breathing or talking,
SARS-CoV-2 aerosol transmission might occur and impact people both near
and far from the source”. As a precaution, the general public should
avoid crowds, he writes, and should also wear masks, “to reduce the risk
of airborne virus exposure”.
Another study failed to find
evidence of SARS-CoV-2 in air samples in isolation rooms at an outbreak
centre dedicated to treating people with COVID-19 in Singapore. Surface
samples from an air outlet fan did return a positive result2, but two of the authors — Kalisvar Marimuthu and Oon Tek Ng at the National Centre for Infectious Diseases in Singapore — told Nature
in an e-mail that the outlet was close enough to a person with COVID-19
that it could have been contaminated by respiratory droplets from a
cough or sneeze.
A similar study by researchers in Nebraska found viral RNA
in nearly two-thirds of air samples collected in isolation rooms in a
hospital treating people with severe COVID-19 and in a quarantine
facility housing those with mild infections3.
Surfaces in ventilation grates also tested positive. None of the air
samples was infectious in cell culture, but the data suggest that “viral
aerosol particles are produced by individuals that have the COVID-19
disease, even in the absence of cough”, the authors write.
The WHO
writes in its latest scientific brief that the evidence of viral RNA
“is not indicative of viable virus that could be transmissible”. The
brief also points to its own analysis of more than 75,000 COVID-19 cases
in China that did not report finding airborne transmission. But Ben
Cowling says that “there wasn't a lot of evidence put forward to support
the assessment” and, an absence of evidence does not mean SARS-CoV-2 is
not airborne. The WHO did not respond to Nature’s questions about the evidence in time for publication.
Scientists
in the United States have shown in the laboratory that the virus can
survive in an aerosol and remain infectious for at least 3 hours4.
Although the conditions in the study were “highly artificial”, there is
probably “a non-zero risk of longer-range spread through the air”, says
co-author Jamie Lloyd-Smith, an infectious-diseases researcher at the
University of California, Los Angeles.
Gaps to fill
Leo
Poon, a virologist at the University of Hong Kong, doesn’t think there’s
enough evidence yet to say SARS-CoV-2 is airborne. He’d like to see
experiments showing that the virus is infectious in droplets of
different sizes.
Whether people with COVID-19 produce enough
virus-laden aerosols to constitute a risk is also unknown, says
Lloyd-Smith. Air sampling from people when they talk, breathe, cough and
sneeze — and testing for viable virus in those samples — “would be
another big part of the puzzle”, he says. One such study failed to
detect viral RNA in air collected 10 centimetres in front of one person
with COVID-19 who was breathing, speaking and coughing, but the authors
didn’t rule out airborne transmission entirely6.
Another
crucial unknown is the infectious dose: the number of SARS-CoV-2
particles necessary to cause an infection, says Lloyd-Smith. “If you’re
breathing aerosolized virus, we don’t know what the infectious dose is
that gives a significant chance of being infected,” he says. An
experiment to get at that number — deliberately exposing people and
measuring the infection rate at different doses — would be unethical
given the disease’s severity.
Whatever the infectious dose, length of exposure is probably
an important factor too, says Tang. Each breath might not produce much
virus, he says, but “if you’re standing beside [someone who’s infected],
sharing the same airspace with them for 45 minutes, you’re going to
inhale enough virus to cause infection”.
But capturing those small
concentrations of aerosols that, given the right combination of
airflow, humidity and temperature, might build to an infectious dose
over time, is “extremely difficult”, says Morawska. “We could say that
we need more data, but then we should acknowledge the difficulty of
collecting the data,” she says.
Cautious approach
The
assumption should be that airborne transmission is possible unless
experimental evidence rules it out, not the other way around, says Tang.
That way people can take precautions to protect themselves, he says.
Increasing
ventilation indoors and not recirculating air can go some way to
ensuring that infectious aerosols are diluted and flushed out, says
Morawska. Indoor meetings should be banned just in case, she says.
Meanwhile,
Lan and others are calling for the public to wear masks to reduce
transmission. Masks are ubiquitous in many countries in Asia. In the
United States and some European countries, however, health officials
have discouraged people from wearing them, in part because supplies are
low and health-care workers need them. The Czech Republic and Slovakia,
however, have made it mandatory for people to wear masks outside the
home. Tang thinks those countries have taken the right approach. “They
are following the southeast Asia approach. If everyone can mask, it is
double, two-way protection,” he says.
But Cowling thinks masks
should be recommended for the public only after supplies have been
secured for health-care workers, people with symptoms, and vulnerable
populations such as the elderly.
(If you’ve not yet been vaccinated, then the symptoms are more recognisable to the traditional original ranking, however we can still observe some changes from when COVID-19 first appeared over a year ago. Headache Sore Throat Runny Nose Fever Persistent cough) This is the order of occurrence. It means that fever is very rare. Not even coughing is common. If you are vaccinated, fever is not even in this top 5 list of common symptoms. Malaysia, and even UK are still using outdated symptoms, not applicable to the Delta variant. https://covid.joinzoe.com/post/new-top-5-covid-symptoms https://covid.joinzoe.com/post/new-top-5-covid-symptoms
Coronavirus: Death of teenager, who had 'just a cough', shakes France Published Mar 27, 2020, 10:16 pm SGT Facebook Twitter PARIS (AFP) - A week ago, 16-year-old Julie came down with a slight cough. On Wednesday (March 25), she became France's youngest Covid-19 fatality, shaking a nation hit by a spiralling health crisis . "We'll never know why," the girl's mother, Sabine, said late on Thursday after France's national health director gave the latest grim toll from the outbreak , now at nearly 1,700 deaths. For many people, the high school student's death brought home what experts have warned - the new virus is not a threat only to the elderly or people with underlying medical problems. "She had just a cough" that anyone might get as winter winds down, Julie's mother said. Initially, they treated it with cough syrup and steam inhalation treatments. By last Saturday, howev...
Conclusion: Chest CT has a high sensitivity for diagnosis of COVID-19. Chest CT may be considered as a primary tool for the current COVID-19 detection in epidemic areas. https://pubs.rsna.org/doi/pdf/10.1148/radiol.2020200642
Comments
Post a Comment